Evaluation of the effect of comorbid bronchiectasis on quality of life in patients with chronic obstructive pulmonary disease

dc.authoridOner, Serkan/0000-0002-7802-880X
dc.authorwosidOner, Serkan/T-2518-2019
dc.contributor.authorYılmaz, Cansu
dc.contributor.authorAcat, Murat
dc.contributor.authorÖner, Serkan
dc.contributor.authorİnci, Habibe
dc.contributor.authorAdahan, Didem
dc.date.accessioned2023-03-22T19:47:19Z
dc.date.available2023-03-22T19:47:19Z
dc.date.issued2022
dc.departmentBelirleneceken_US
dc.description.abstractObjective: The objective of this study was to evaluate the effect of comorbid bronchiectasis on quality-of-life in patients with Chronic Obstructive Pulmonary Disease (COPD). Method: 103 patients were diagnosed with COPD were included in our study. Spirometric measurements were made. The following measurement tools were used to collect data: 6-Minute Walk Test (6MWT), Modified Medical Research Council (mMRC) dyspnea scale, COPD Assessment Test (CAT), St. George Respiratory Questionnaire (SGRQ), and Short Form 36 (SF-36) quality-of-life questionnaire. Furthermore, all the patients' high Resolution Computed Tomography (HRCT) images for the last three years were included in the study. Result: 93.2% of the patients were male, with a mean age of 64.79 +/- 9.35 years. It was found that SGRQ and SF-36 quality-of-life scores decreased by half in all the patients compared to normal ones. The volume/forced vital capacity (FEV1/FVC) values in the first second of forced expiration were significantly lower in the group with bronchiectasis. A significant correlation was found to exist between the patients' mMRC dyspnea scale and CAT scores, 6MWT distances, and all subscales of SGRQ and SF-36. In addition, a significant correlation was also found to exist between FEV1 values and all subscales of SGRQ, and between subscales of SF-36. Conclusion: In our study, when we compared the quality-of-life scores of the patients with COPD and bronchiectasis with those with COPD alone, we found that the quality-of-life of both groups was impaired, but there was no significant difference between them.en_US
dc.identifier.doi10.18521/ktd.997761
dc.identifier.endpage365en_US
dc.identifier.issn1309-3878
dc.identifier.issue2en_US
dc.identifier.startpage357en_US
dc.identifier.trdizinid1121019en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14034/611
dc.identifier.urihttps://doi.org/10.18521/ktd.997761
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1121019
dc.identifier.volume14en_US
dc.identifier.wosWOS:000821703000010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherDuzce Univ, Fac Medicineen_US
dc.relation.journalKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBronchiectasisen_US
dc.subjectChronic Obstructive Pulmonary Diseaseen_US
dc.subjectQuality of Lifeen_US
dc.subjectTurkish Versionen_US
dc.subjectHealth-Statusen_US
dc.subjectReliabilityen_US
dc.subjectValidationen_US
dc.subjectValidityen_US
dc.titleEvaluation of the effect of comorbid bronchiectasis on quality of life in patients with chronic obstructive pulmonary diseaseen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Evaluation of the Effect of Comorbid.pdf
Boyut:
827.85 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text